Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective
A Akil, AK Gutiérrez-García, R Guenter… - Frontiers in cell and …, 2021 - frontiersin.org
The Notch signaling pathway plays an essential role in a wide variety of biological
processes including cell fate determination of vascular endothelial cells and the regulation …
processes including cell fate determination of vascular endothelial cells and the regulation …
The strategies to cure cancer patients by eradicating cancer stem-like cells
Y Mai, J Su, C Yang, C Xia, L Fu - Molecular Cancer, 2023 - Springer
Cancer stem-like cells (CSCs), a subpopulation of cancer cells, possess remarkable
capability in proliferation, self-renewal, and differentiation. Their presence is recognized as a …
capability in proliferation, self-renewal, and differentiation. Their presence is recognized as a …
Advances in ovarian cancer treatment beyond PARP inhibitors
F Aliyuda, M Moschetta, A Ghose… - Current Cancer Drug …, 2023 - ingentaconnect.com
Ovarian cancer has become the largest cause of gynaecological cancer-related mortality. It
is typically diagnosed at a late stage and has no effective screening strategy. Ovarian cancer …
is typically diagnosed at a late stage and has no effective screening strategy. Ovarian cancer …
Evolving strategies for management of desmoid tumor
RF Riedel, M Agulnik - Cancer, 2022 - Wiley Online Library
Desmoid tumors (DTs) are rare soft tissue mesenchymal neoplasms that may be associated
with impairments, disfigurement, morbidity, and (rarely) mortality. DT disease course can be …
with impairments, disfigurement, morbidity, and (rarely) mortality. DT disease course can be …
Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition
N Federman - NPJ precision oncology, 2022 - nature.com
Desmoid tumor (DT) is a rare, soft tissue neoplasm associated with an unpredictable clinical
course. Although lacking metastatic potential, DT is often locally aggressive and invasive …
course. Although lacking metastatic potential, DT is often locally aggressive and invasive …
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation
We here defined the impacts of γ-secretase inhibitors (GSIs) on T-cell-dependent BCMA-
specific multiple myeloma (MM) cell lysis and immunomodulatory effects induced by …
specific multiple myeloma (MM) cell lysis and immunomodulatory effects induced by …
Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance
M Feng, RK Santhanam, H Xing, M Zhou… - Biochemical Pharmacology, 2024 - Elsevier
The mechanism of tumor drug resistance is complex and may involve stem cell
maintenance, epithelial-mesenchymal transition, the activation of survival signaling …
maintenance, epithelial-mesenchymal transition, the activation of survival signaling …
Engineering receptors in the secretory pathway for orthogonal signalling control
M Mahameed, P Wang, S Xue… - Nature …, 2022 - nature.com
Synthetic receptors targeted to the secretory pathway often fail to exhibit the expected
activity due to post-translational modifications (PTMs) and/or improper folding. Here, we …
activity due to post-translational modifications (PTMs) and/or improper folding. Here, we …
New precision medicine avenues to the prevention of Alzheimer's disease from insights into the structure and function of γ-secretases
B De Strooper, E Karran - The EMBO Journal, 2024 - embopress.org
Two phase-III clinical trials with anti-amyloid peptide antibodies have met their primary goal,
ie slowing of Alzheimer's disease (AD) progression. However, antibody therapy may not be …
ie slowing of Alzheimer's disease (AD) progression. However, antibody therapy may not be …
Jagged1 intracellular domain/SMAD3 complex transcriptionally regulates TWIST1 to drive glioma invasion
JY Kim, N Hong, S Park, SW Ham, EJ Kim… - Cell Death & …, 2023 - nature.com
Abstract Jagged1 (JAG1) is a Notch ligand that correlates with tumor progression. Not
limited to its function as a ligand, JAG1 can be cleaved, and its intracellular domain …
limited to its function as a ligand, JAG1 can be cleaved, and its intracellular domain …